Promethazine Tablets: Indications and Dosage
Promethazine tablets are indicated for allergic reactions, nausea/vomiting, sedation, and motion sickness, with standard adult dosing of 12.5-25 mg orally every 4-6 hours, not to exceed 100 mg daily, and are contraindicated in children under 2 years of age.
Primary Indications
Promethazine is a phenothiazine with multiple therapeutic properties that make it useful across several clinical scenarios 1, 2:
- Antihistamine effects: Management of allergic reactions and anaphylaxis
- Antiemetic effects: Treatment of nausea and vomiting (postoperative, chemotherapy-induced, or general)
- Sedative effects: Adjuvant for postoperative pain and sedation
- Anti-motion sickness: Prevention and treatment of motion sickness
The drug works by blocking postsynaptic dopaminergic receptors and acting as a competitive histamine H1-receptor antagonist, with additional anticholinergic properties 1.
Dosage Recommendations
Standard Adult Dosing
For oral administration, the typical dose is 12.5-25 mg every 4-6 hours as needed 3, 4. The FDA-approved labeling confirms these parameters 5.
Specific Clinical Contexts
Antiemetic use (breakthrough nausea/vomiting):
- 12.5-25 mg orally every 4-6 hours
- Alternative: 25 mg suppository rectally every 6 hours 4
Sedation/sleep aid:
- 20-40 mg at bedtime (though this indication is increasingly questioned - see caveats below) 6
Motion sickness:
- 25 mg taken 30-60 minutes before travel, repeated every 4-6 hours as needed 7
Pharmacokinetics
- Onset of action: 5 minutes (IV), several minutes (oral)
- Duration: 4-6 hours
- Half-life: 9-16 hours 1, 2
Critical Safety Considerations
Black Box Warning - Pediatric Use
Promethazine is absolutely contraindicated in children under 2 years of age due to risk of fatal respiratory depression 2, 5. Use with extreme caution in children 2 years and older, starting with the lowest effective dose.
Injectable Formulation Risks
While your question asks about tablets specifically, it's crucial to note that injectable promethazine carries serious risks of tissue necrosis, gangrene, and thrombophlebitis with extravasation or inadvertent intra-arterial injection 2, 8. The FDA updated labeling in 2023 to recommend intramuscular over intravenous administration when parenteral use is necessary 8. Many institutions have removed injectable promethazine from formularies entirely 9.
Common Adverse Effects
- Hypotension (infuse slowly if using IV formulation)
- Respiratory depression (especially when combined with opioids or benzodiazepines)
- CNS depression and marked drowsiness
- Extrapyramidal effects (restlessness to oculogyric crises)
- Neuroleptic malignant syndrome (rare)
- Anticholinergic effects (dry mouth, urinary retention, confusion in elderly) 1, 2, 5
Drug Interactions
When used with CNS depressants (opioids, benzodiazepines, alcohol), reduce doses significantly:
- Reduce barbiturate dose by at least 50%
- Reduce narcotic dose by 25-50% 5
Avoid epinephrine for hypotension - promethazine can reverse epinephrine's vasopressor effect 5.
Special Populations
Elderly Patients
Start at the low end of dosing range (12.5 mg). Sedating antihistamines cause confusion and over-sedation in older adults more frequently 5. The anticholinergic burden is particularly problematic in those with cognitive impairment, prostatic hypertrophy, or glaucoma 7.
Pregnancy
Category C - use only if potential benefit justifies risk. May inhibit platelet aggregation in newborns if used within 2 weeks of delivery 5.
Renal/Hepatic Impairment
Dose reduction recommended, though specific guidance is limited. Start conservatively 5.
Contemporary Clinical Context
The role of promethazine is evolving and increasingly restricted 9, 10. For antiemetic use, newer agents (5-HT3 antagonists like ondansetron, NK1 antagonists) provide comparable or superior efficacy with better safety profiles 4, 9. For sleep, promethazine lacks good evidence and may interfere with cognitive-behavioral therapy for insomnia, which is the NICE first-line recommendation 10.
When promethazine is used, oral formulation is strongly preferred over injectable to avoid catastrophic tissue injury risks 8, 9.
Practical Prescribing Algorithm
- Verify age: Absolutely no use under 2 years
- Choose indication: Antiemetic, antihistamine, or sedation
- Start with 12.5-25 mg orally every 4-6 hours
- Adjust for elderly: Begin at 12.5 mg
- Monitor for: Excessive sedation, anticholinergic effects, extrapyramidal symptoms
- Consider alternatives: Ondansetron for nausea, second-generation antihistamines for allergies, CBT-I for insomnia